BRUSSELS – The EU drug regulator yesterday updated the product information slip for the AstraZeneca vaccine to include a warning about rare blood clotting, reported Sputnik.
“Very rare blood clots, often in unusual locations (eg brain, bowel, liver, spleen), in combination with low level of blood platelets, in some cases together with bleeding, has been observed,” it now reads.
The advisory adds that the majority of these cases occurred within the first 14 days following vaccination and occurres mostly in women under 60 years old. Some cases have also had a fatal outcome, it reads.
After studying 86 cases of unusual post-shot blood clotting, including 18 fatal ones, the EU regulator concluded that these should be listed as “very rare side effects” of the vaccine. – Bernama, April 9, 2021
.jpeg)
.jpg)
